4.8 Article

Exosomes from Glioma-Associated Mesenchymal Stem Cells Increase the Tumorigenicity of Glioma Stem-like Cells via Transfer of miR-1587

Journal

CANCER RESEARCH
Volume 77, Issue 21, Pages 5808-5819

Publisher

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/0008-5472.CAN-16-2524

Keywords

-

Categories

Funding

  1. NIH [5R01 CA115729-05]
  2. National Cancer Institute
  3. SPORE in Brain Cancer [1P50 CA127001-06]
  4. Broach Foundation for Brain Cancer Research
  5. Elias Family Fund
  6. NIH/NCI [1UH2TR00943-01, 1 R01 CA182905-01]
  7. UT MD Anderson Cancer Center Brain SPORE [2P50CA127001]
  8. Gene Pennebaker Brain Cancer Fund
  9. Ben and Catherine Ivy Foundation
  10. Anthony Bullock III Foundation
  11. Brian McCulloch Fund
  12. Uncle Kory Foundation
  13. Jason & Priscilla Hiley Fund

Ask authors/readers for more resources

Tumor-stromal communications impact tumorigenesis in ways that are incompletely understood. Here, we show that glioma-associated human mesenchymal stem cells (GA-hMSC), a newly identified stromal component of glioblastoma, release exosomes that increase the proliferation and clonogenicity of tumor-initiating glioma stem-like cells (GSC). This event leads to a significantly greater tumor burden and decreased host survival compared with untreated GSCs in orthotopic xenografts. Analysis of the exosomal content identified miR-1587 as a mediator of the exosomal effects on GSCs, in part via downregulation of the tumor-suppressive nuclear receptor corepressor NCOR1. Our results illuminate the tumor-supporting role for GA-hMSCs by identifying GA-hMSC-derived exosomes in the intercellular transfer of specific miRNA that enhance the aggressiveness of glioblastoma. (C) 2017 AACR.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available